suckstradin... Sorry I didn't get back to you. I wasn't snubbing you. The hedge makes money. I don't think they could run it down past 2.00 without all kinds of buyers stepping in? So they got it close and then gathered all kinds of peeps on the way to 2.45 and just used that walk about to gather and cover.
I was just thinking about the MCAP on this one?
CYCC Cyclacel Pharmaceuticals, Inc. NASDAQ-GM
Institutional New Positions Description | Hide Summary
Company Details Total Shares Out Standing (millions): 31
Market Capitalization ($ millions): $70
Institutional Ownership: 29.1%
Price (as of 1/25/2010) 2.22
Ownership Analysis # Of Holders Shares Total Shares Held: 20 9,147,363
New Positions: 3 4,042,979
Increased Positions: 6 4,307,135
Decreased Positions: 10 267,777
Holders With Activity: 16 4,574,912
Sold Out Positions: 9 265,447
With an MCAP of 70 Million @ a PPS of 2.22 is way undervalued.
With just 30% of a Billion dollar a year market that would generate 333 million gross or a 100 million net.
Trading at 10 times forward earnings that would put the company at a Billion domllars MCAP or a PPS of 1000/70 = 14.28
Times the level its now trading at? 14.28 X 2.22 = PPS of $31.70?
Sorry guys and girls, this is an off topic message for snob Hi snob, tomorrow morning there might be a good chance to pick up the last cheap SOMX shares.
Jan. 20 meeting with senior leadership at the FDA dramatically changed the firm's near-term prospects. Without asking for additional safety or efficacy data - instead requiring only the resubmission of a pre-meeting briefing package - the FDA allowed Somaxon to resubmit its application for Silenor the following day and set a new PDUFA date of March 21.